SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000894158-05-000004
Filing Date
2005-07-15
Accepted
2005-07-15 11:37:49
Documents
3
Period of Report
2005-07-15
Items
Item 1.03: Bankruptcy or Receivership
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 sffp-8k.htm 8-K 25829
2 exh2_1.htm EX-2 9419
3 exh_16.htm EX-16 794
  Complete submission text file 0000894158-05-000004.txt   37875
Mailing Address 1220 GLENMORE DRIVE APOPKA FL 32712
Business Address 1220 GLENMORE DRIVE APOPKA FL 32712 407-880-2213
SHEFFIELD PHARMACEUTICALS INC (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 05956248
SIC: 2834 Pharmaceutical Preparations